References
- Arellano M, Lonial S. 2008. Clinical uses of GM-CSF, a critical appraisal and update. Biologics. 2:13-27.
- Barreda DR, Hanington PC, Belosevic M. 2004. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol. 28:509-554. https://doi.org/10.1016/j.dci.2003.09.010
- Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic- Canic M. 2008. Growth factors and cytokines in wound healing. Wound Repair Regen. 16:585-601. https://doi.org/10.1111/j.1524-475X.2008.00410.x
- Braunstein S, Kaplan G, Gottlieb AB, Schwartz M, Walsh G, Abalos RM, Fajardo TT, Guido LS, Krueger JG. 1994. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J Invest Dermatol. 103:601-604. https://doi.org/10.1111/1523-1747.ep12396936
- Cianfaran F, Tommasi R, Failla CM, Viviano MT, Annessi G, Papi M, Zambruno G, Odorisio T. 2006. Granulocyte/ macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol. 154:34-41. https://doi.org/10.1111/j.1365-2133.2005.06925.x
- Dorsett-Martin WA. 2004. Rat models of skin wound healing: a review. Wound Repair Regen. 12:591-599. https://doi.org/10.1111/j.1067-1927.2004.12601.x
- Fang Y, Gong SJ, Xu YH, Hambly BD, Bao S. 2007. Impaired cutaneous wound healing in granulocyte/ macrophage colony-stimulating factor knockout mice. Br J Dermatol. 157:458-465. https://doi.org/10.1111/j.1365-2133.2007.07979.x
- Gasson JC. 1991. Molecular physiology of granulocytemacrophage colony-stimulating factor. Blood. 77: 1131-1145.
- Haroon ZA, Hettasch JM, Lai TS, Dewhirst MW, Greenberg CS. 1999. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J. 13:1787-1795. https://doi.org/10.1096/fasebj.13.13.1787
- Hill AD, Naama HA, Calvano SE, Daly JM. 1995. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications. J Leukoc Biol. 58:634-642. https://doi.org/10.1002/jlb.58.6.634
- Jackson DM. 1953. The diagnosis of the depth of burning. Br J Surg. 40:588-596. https://doi.org/10.1002/bjs.18004016413
- Khodadadi L, Shafieyan S, Aghdami N, Baharvand H. 2008. Cell therapy in burn repair. Yakhteh Med J. 10:167-178.
- Kim HJ, Lee DH, Kim DK, Han GB, Kim HJ. 2008. The glycosylation and in vivo stability of human granulocytemacrophage colony-stimulating factor produced in rice cells. Biol Pharm Bull. 31:290-294. https://doi.org/10.1248/bpb.31.290
- Masucci G. 1996. New clinical applications of granulocytemacrophage colony-stimulating factor. Med Oncol. 13:149-154.
- Matsumotoa K, Nakamurab T. 1999. Hepatocyte growth factor and met: Molecular dialogue for tissue organization and repair. Animal Cell Syst (Former. Korean J Biol Sci), 2:1-8.
- Mery L, Girot R, Aractingi S. 2004. Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers. Dermatology. 208:135-137. https://doi.org/10.1159/000076487
- Odland G, Ross R. 1968. Human wound repair. J Cell Biol. 39:135-168. https://doi.org/10.1083/jcb.39.1.135
- Yamamoto Y, Uede K, Yonei N, Furukawa F. 2007. Expression patterns of proliferating cell nuclear antigen in trichloroacetic acid peeled skin. J Dermatol. 34:95-98. https://doi.org/10.1111/j.1346-8138.2006.00225.x
Cited by
- Polydeoxyribonucleotide administration promotes the expression of proliferating cell nuclear antigen during liver regeneration in rats vol.19, pp.1, 2015, https://doi.org/10.1080/19768354.2014.997289